← Back to Patent Explorer
US4943595A Expired / Lapsed US ⏱️ 0.0 years remaining

Perfluorochemicals and process for preparing the same

Assignee: Tanabe Pharma Corp
•
Filing: 1984-02-22
•
Granted: 1990-07-24
•
Expires: 2004-02-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is provided a novel perfluorochemical represented by the formula, <IMAGE> wherein RF is a perfluoroalkyl group, a perfluoro alkoxyalkyl group or a perfluoroalkyloxy group, X and X' are same as or different from each other and are a fluorine atom or a perfluoroalkyl group, and Y is a perfluoroalkyloxy group or a perfluoro dialkylamino group, the total number of the carbon atoms contained being an integer of 8 to 11 inclusive. The perfluorochemical is prepared by perfluorinating the corresponding partially fluorinated compound which may have unsaturated hydrocarbon moiety, only with molecular fluorine in a stoichiometric excess amount in an inert solvent. The perfluorochemical is used for preparing a stable emulsion as blood substitutes or perfusion media.

Inventors

  • 👤 Kirby V. Scherer, Jr.
  • 👤 Kouichi Yamanouchi
  • 👤 Kazumasa Yokoyama
  • 👤 Ryoichi Naito, deceased

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 16:35
CPC Classifications
C; C07; C07C; C07C43/00; C07C43/02; C07C43/03; C07C43/04; C07C43/12; C07C43/123; C07C43/126; C07C43/14; C07C43/17; C07C43/30; C07C43/313

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 97 words
A perfluoroether derivative suitable for use in a blood substitute and of the formula ##STR65## wherein: R Fl is a C 3 -C 7 perfluoroalkyl group, X 1 is a fluorine atom or a C 1 -C 3 perfluoroalkyl group and X 2 is a C 1 -C 3 perfluoroalkyl group, and RF 2 is a perfluoro C 2 -C 5 -alkyl group, the total number of the carbon atoms contained in the perfluoroalkyl ether derivative being 10 to 11, inclusive, with the proviso that there is at least one branched chain perfluoroalkyl group in the molecule.
Claim 2
Dependent Claim 97 words
A perfluoroether derivative suitable for use in a blood substitute and of the formula ##STR65## wherein: R Fl is a C 3 -C 7 perfluoroalkyl group, X 1 is a fluorine atom or a C 1 -C 3 perfluoroalkyl group and X 2 is a C 1 -C 3 perfluoroalkyl group, and RF 2 is a perfluoro C 2 -C 5 -alkyl group, the total number of the carbon atoms contained in the perfluoroalkyl ether derivative being 10 to 11, inclusive, with the proviso that there is at least one branched chain perfluoroalkyl group in the molecule.
Claim 3
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-3-n-butoxy-2-methylpentane.
Claim 4
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-3-isobutoxy-2-methylpentane.
Claim 5
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-3-sec-butoxy-2-methylpentane.
Claim 6
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-3-isopentoxy-2-methylpentane.
Claim 7
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-3-n-propoxy-2,4-dimethylpentane.
Claim 8
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-3-isopropoxy-2,4-dimethylpentane.
Claim 9
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-3-n-butoxy-2,4-dimethylpentane.
Claim 10
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-3-isobutoxy-2,4-dimethylpentane.
Claim 11
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-2-n-butoxy-2-methylpentane.
Claim 12
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-2-isobutoxy-2-methylpentane.
Claim 13
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-2-sec-butoxy-2-methylpentane.
Claim 14
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-2-isopentoxy-2-methylpentane.
Claim 15
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-2-ethoxy-4-ethyl-4-methylhexane.
Claim 16
Dependent Claim 10 words
The perfluoroalkyl ether derivative of claim 1 which is perfluoro-2-ethoxy-3-isopropyl-4-methylpentane.
Claim 17
Dependent Claim 10 words
An emulsion containing the perfluoroalkyl ether derivative of claim 1.

References Cited (Backward Citations)

US2500388A Cited
US3242218A Cited
US3214478A Cited
US3278615A Cited
US3435078A Cited
DE2253534A1 Cited
US4252827A Cited
US4523039A Cited
US4510335A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-07-23 1994-01-22 1994-07-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-07-23 1998-01-22 1998-07-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-07-23 2002-01-22 2002-07-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag